SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-018767
Filing Date
2022-08-04
Accepted
2022-08-04 09:15:41
Documents
17
Period of Report
2022-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20220803_8k.htm   iXBRL 8-K 61089
2 EXHIBIT 3.1 ex_406122.htm EX-3.1 113213
3 EXHIBIT 4.1 ex_406123.htm EX-4.1 115621
4 EXHIBIT 10.1 ex_406124.htm EX-10.1 202740
5 EXHIBIT 10.2 ex_406125.htm EX-10.2 134189
  Complete submission text file 0001437749-22-018767.txt   900226

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20220803.xsd EX-101.SCH 3600
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20220803_def.xml EX-101.DEF 11915
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20220803_lab.xml EX-101.LAB 15955
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20220803_pre.xml EX-101.PRE 12126
11 EXTRACTED XBRL INSTANCE DOCUMENT acrx20220803_8k_htm.xml XML 2668
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 221135025
SIC: 2834 Pharmaceutical Preparations